Galecto Inc (GLTO)
0.68
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
0.68
0.00 (0.00%)
After-Hours: 20:00
Galecto Cash from Investing (TTM): 22.33M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 22.33M |
September 30, 2023 | 27.08M |
June 30, 2023 | 27.11M |
March 31, 2023 | 23.96M |
December 31, 2022 | 12.38M |
September 30, 2022 | 12.47M |
June 30, 2022 | 11.20M |
Date | Value |
---|---|
March 31, 2022 | 16.38M |
December 31, 2021 | -48.05M |
September 30, 2021 | -62.46M |
June 30, 2021 | -69.51M |
March 31, 2021 | -74.63M |
December 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-74.63M
Minimum
Mar 2021
27.11M
Maximum
Jun 2023
-7.826M
Average
12.38M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
Novo Nordisk A/S | -6.373B |
Genmab A/S | -186.13M |
Ascendis Pharma A/S | 310.14M |
Evaxion Biotech AS | -- |
IO Biotech Inc | -0.323M |